Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.40
Bid: 123.20
Ask: 124.00
Change: 1.60 (1.31%)
Spread: 0.80 (0.649%)
Open: 122.00
High: 125.40
Low: 122.00
Prev. Close: 121.80
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EGM

20 Mar 2013 14:57

RNS Number : 4832A
HICL Infrastructure Company Ld
20 March 2013
 



20 March 2013

 

HICL Infrastructure Company Limited (the "Company")

 

Result of Extraordinary General Meeting

 

The Board of the Company is pleased to announce that each of the special resolutions put to shareholders at the Extraordinary General Meeting held on 20 March 2013 were passed. The details of each such resolution are as follows: 

 

 

ORDINARY RESOLUTION 1

 

 

 

 

 

 

 

 

 

The Chairman advised that the following votes on a poll had been received:

 

Nominal

Percentage

In Favour

280,248,977

99.997

Against

8,000

0.003

 

That the proposed purchases by the Group from InfraRed Infrastructure Fund II of a 29.2 per cent. equity and loan note interest in the Bradford Schools Project and a 50 per cent. equity and loan note interest in the University of Sheffield Project on such terms as may be agreed by the Group and InfraRed Infrastructure Fund II, subject to all other actions necessary to effect such purchase, be and are hereby approved.

 

 

SPECIAL RESOLUTION 1

 

 

 

 

 

 

 

 

The Chairman advised that the following votes on a poll had been received:

 

Nominal

Percentage

In Favour

279,250,037

99.641

Against

1,006,940

0.359

 

That: (i) the Issue on the terms and subject to the conditions described in the Circular be and is hereby approved; and (ii) the Directors be and hereby are empowered to allot up to 140 million Ordinary Shares for cash (in substitution for any existing such power or authority other than pursuant to Special Resolution 2), as if Article 9 of the Company's Articles did not apply to the allotment, provided that:

(a) this power shall (unless previously revoked, varied or renewed by the Company) expire on 31 May 2013, provided that the Company may before such expiry, make an offer or agreement which would or might require Ordinary Shares to be allotted after such expiry and Ordinary Shares may be allotted in pursuance of such an offer or agreement as if the power conferred by this resolution had not expired; and

(b) this power shall be limited to the allotment of New Ordinary Shares under the Issue.

 

 

SPECIAL RESOLUTION 2

 

 

The Chairman advised that the following votes on a poll had been received:

 

Nominal

Percentage

In Favour

277,402,017

98.981

Against

2,854,960

1.019

 

That the Directors be and hereby are empowered to allot up to 10.0 per cent. of the Ordinary Shares of the Company in issue immediately following the completion of the Issue (or, if the Issue does not proceed, the date of the publication by the Company of an announcement to this effect) for cash (in substitution for any existing such power or authority other than pursuant to Special Resolution 1), as if Article 9 of the Company's Articles did not apply to the allotment for the period expiring on the date falling 15 months after the date of the passing of this resolution or the conclusion of the next annual general meeting of the Company, which ever is the earlier, provided that the Company may before such expiry, make an offer or agreement which would or might require Ordinary Shares to be allotted after such expiry and Ordinary Shares may be allotted in pursuance of such an offer or agreement as if the power conferred by this resolution had not expired.

 

 

 

 

 

 In accordance with Listing Rule 9.6.2, a copy of the special resolutions above have been forwarded to the National Storage Mechanism.

 

For further information, please contact:

 

Gillian Newton/Christopher Copperwaite

Dexion Capital (Guernsey) Limited

 

 

+44 (0)1481 732814/732815

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REGSEIFLSFDSEID
Date   Source Headline
11th Jun 20185:30 pmRNSAnnual Financial Report
11th Jun 20187:00 amRNSIncremental Acquisition
1st Jun 201811:01 amRNSScrip Dividend Alternative - Suspension
30th May 20188:31 amRNSDirector/PDMR Shareholding
29th May 20184:00 pmRNSDirector/PDMR Shareholding
25th May 201810:00 amRNSEU GDPR Data Privacy Notices
23rd May 20187:00 amRNSAnnual Financial Report
16th May 20182:00 pmRNSFourth Quarterly Interim Dividend
30th Apr 20187:00 amRNSDisposal of an investment
27th Apr 20187:00 amRNSNew Investments
17th Apr 20183:13 pmRNSDirector Declaration
17th Apr 201810:02 amRNSDirectorate Change
16th Apr 20187:25 amRNSNotice of Annual Results
16th Apr 20187:25 amRNSNew Investment
5th Apr 20183:00 pmRNSDirector/PDMR Shareholding
29th Mar 201812:00 pmRNSTotal Voting Rights
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 201812:00 pmRNSAdditional Listing
26th Mar 20187:00 amRNSIncremental Investment
21st Mar 20185:02 pmRNSDirector/PDMR Shareholding
19th Mar 20182:43 pmRNSDirector Declaration
8th Mar 20185:30 pmRNSScrip Share Reference Price
2nd Mar 20182:00 pmRNSDirector/PDMR Shareholding
21st Feb 201812:52 pmRNSThird Quarterly Interim Dividend
7th Feb 201811:36 amRNSCapital Markets Seminar
5th Feb 20187:00 amRNSInterim Update Statement
1st Feb 20187:00 amRNSRenewal of the Group's Revolving Credit Facility
30th Jan 20188:00 amRNSDirector/PDMR Shareholding
29th Jan 20185:05 pmRNSDirector/PDMR Shareholding
29th Jan 20182:20 pmRNSDirector/PDMR Shareholding
29th Jan 20182:19 pmRNSDirector/PDMR Shareholding
26th Jan 20185:12 pmRNSDirector/PDMR Shareholding
26th Jan 20185:10 pmRNSDirector/PDMR Shareholding
26th Jan 20183:54 pmRNSDirector/PDMR Shareholding
26th Jan 20183:53 pmRNSDirector/PDMR Shareholding
26th Jan 20187:00 amRNSUpdate on Service Provision
15th Jan 20188:55 amRNSService Provision Continuity
3rd Jan 20183:00 pmRNSDirector/PDMR Shareholding
29th Dec 20171:30 pmRNSTotal Voting Rights
22nd Dec 201710:22 amRNSAdditional Listing
21st Dec 20175:00 pmRNSPublication of Interim Report
20th Dec 201711:00 amRNSKey Information Document
30th Nov 20173:00 pmRNSScrip Share Reference Price
27th Nov 20177:00 amRNSDirector/PDMR Shareholding
22nd Nov 20177:00 amRNSInterim Results Six Months Ended 30 September 2017
16th Nov 20177:00 amRNSSecond Quarterly Interim Dividend
4th Oct 20177:00 amRNSDirector/PDMR Shareholding 30 September 2017
29th Sep 20173:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.